Association between 25-hydroxyvitamin D levels and COVID-19 severity.
Association between 25-hydroxyvitamin D levels and COVID-19 severity.
复制标题
DOI:
10.1016/j.clnesp.2022.04.003
复制
发表时间:
2022-06
影响因子:
3
通讯作者:
Muroi N
中科院分区:
文献类型:
--
作者:
Takase T;Tsugawa N;Sugiyama T;Ikesue H;Eto M;Hashida T;Tomii K;Muroi N
Despite reports on the impact of vitamin D status on coronavirus disease 2019 (COVID-19) severity, the association between low vitamin D status and severe COVID-19 remains unclear. Moreover, researchers have not determined the aforementioned association in Japanese patients. This study aimed to investigate the association between 25-hydroxyvitamin D [25(OH)D] levels and COVID-19 severity in Japanese patients. This retrospective observational study included 117 consecutive patients with COVID-19 admitted to the Kobe City Medical Center General Hospital between October 01, 2020, and January 31, 2021. We measured the serum 25(OH)D levels using blood specimens collected within 5 days of hospital admission using liquid chromatography-tandem mass spectrometry. There were 21 (17.9%), 73 (62.4%), 19 (16.2%) and 4 (3.4%) patients with severe deficiency (<10 ng/mL), deficiency (10–<20 ng/mL), insufficiency (20–<30 ng/mL), and sufficiency (≥30 ng/mL) of vitamin D, respectively. In univariate logistic regression analyses, lower serum 25(OH)D levels [odds ratio (OR) 1.18 per 1 ng/mL decrease, 95% confidence interval (CI) 1.04–1.33, p = 0.007] were significantly associated with invasive mechanical ventilation (IMV) or death. In a multivariate logistic regression analysis, low serum 25(OH)D levels [OR 1.22 per 1 ng/mL decrease, 95% CI 1.06–1.40, p = 0.005] were significantly associated with IMV or death. The cut-off value of serum 25(OH)D levels was 10.4 ng/mL, calculated by the receiver operating characteristic curve to detect the requirement for IMV or death. To the best of our knowledge, this is the first study to assess the association between vitamin D status and COVID-19 severity in Japanese patients. Low serum 25(OH)D level was detected as an independent risk factor for severe COVID-19 among Japanese patients.
登录
查看更多内容
影响因子:
3.7
作者:
Davoudi A;Najafi N;Aarabi M;Tayebi A;Nikaeen R;Izadyar H;Salar Z;Delavarian L;Vaseghi N;Daftarian Z;Ahangarkani F
通讯作者:
Ahangarkani F
影响因子:
3.5
作者:
De Smet, Dieter;De Smet, Kristof;Martens, Geert A.
通讯作者:
Martens, Geert A.
影响因子:
168.9
作者:
Huang, Chaolin;Wang, Yeming;Cao, Bin
通讯作者:
Cao, Bin
DOI:
10.1136/bmj.i6583
发表时间:
2017-02-15
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Martineau AR;Jolliffe DA;Hooper RL;Greenberg L;Aloia JF;Bergman P;Dubnov-Raz G;Esposito S;Ganmaa D;Ginde AA;Goodall EC;Grant CC;Griffiths CJ;Janssens W;Laaksi I;Manaseki-Holland S;Mauger D;Murdoch DR;Neale R;Rees JR;Simpson S Jr;Stelmach I;Kumar GT;Urashima M;Camargo CA Jr
通讯作者:
Camargo CA Jr
影响因子:
5.9
作者:
Karonova TL;Andreeva AT;Golovatuk KA;Bykova ES;Simanenkova AV;Vashukova MA;Grant WB;Shlyakhto EV
通讯作者:
Shlyakhto EV